The endocannabinoid system (ECS) is a combination of endocannabinoids, enzymes and cannabinoid receptors that helps regulate several functions in the human body.
Research on the ECS is still fairly recent. We know cannabinoids are structurally similar to endocannabinoids and enter the body through ECS cannabinoid receptors, offering certain therapeutic and psychoactive effects.
The Cannabis Act is a federal law that came into force Oct. 17, 2018, legalizing access to recreational cannabis in Canada. The law governs the production, distribution, sale and possession of cannabis across Canada and protects public health and safety.
Each province and territory is responsible for setting its own rules around how cannabis can be sold and where stores may be located, among other regulations. In Ontario, recreational cannabis is available for purchase only by adults 19 years of age or older and only through Authorized Cannabis Stores and OCS.ca. It is illegal to purchase cannabis from non-licensed sources.
Learn more about who does what in the sale of legal cannabis.
Often used in the production of edibles and infused beverages, nanoemulsion refers to cannabinoids that are broken down into microscopic molecules that are suspended in a lipid, or fat, allowing them to travel to their desired destination in the body more quickly and in greater quantities. Instead of being gradually metabolized in the liver and stomach, these tiny cannabinoids move directly into the bloodstream, producing a faster onset of effects.
Products formulated with nanoemulsion may feature terms like “quick onset” or “fast-acting.” Research into the nanoemulsification of cannabinoids and the potential effects is ongoing.